LA JOLLA, Calif., Nov. 17, 2018 /PRNewswire-PRWeb/ -- Imagine
Global Care Corp, a life sciences company developing natural,
clinically tested health and wellness products based on
phytonutrient research, today announced the publication of the
first clinical trial of its recently launched bitter melon
supplement: Goyamin.
The double-blind, placebo controlled trial was accepted for
publication in the peer-reviewed journal Evidence-Based
Complementary and Alternative Medicine. The clinical trial results
demonstrated a significant decrease in LDL cholesterol with
continued daily use of the product over a 30 day period.
This is the first-ever bitter melon supplement to show clinical
evidence of having cholesterol-related health benefits. "After so
much went into the research and development of this product, we
were very excited to see these results," said President and CEO
Hiroki Kinoshita. "Our goal as a
company has always been to connect people with natural health
solutions that have been scientifically validated. We all know, in
a general sense, how powerful and beneficial phytonutrients can be,
but it is not enough to rely on the general sense. These types of
studies allow us to understand these benefits in a very specific
and very precise way."
Goyamin is a superfood extracted from bitter melon (also called
goya), locally grown in Okinawa, a
blue-zone area, which is rated by National Geographic as one of the
healthiest places on earth, with high concentrations of people
living to 100 years or more thanks to a diet rich in vegetables,
especially goya.
The clinical trial can be viewed at
https://www.hindawi.com/journals/ecam/2018/4915784/
About
Imagine Global Care is on a mission to change the way people
approach preventative medicine. The company, which shares a
research partnership with the University of
Tokyo, focuses on emerging phytonutrient research with the
aim to make these scientific advancements readily available to the
people who need them. Learn more at
http://www.imagineglobalcare.com.
SOURCE Imagine Global Care Corp